Home >

Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

As the host of the ASCO in Action podcast series, I'll be interviewing leaders and experts in oncology about policy and practice issues. Our first episode is about representation in the oncology workforce.
ASCO urges Congress to protect Medicare beneficiaries with cancer and other medical conditions by passing additional legislation to avoid cuts to the program.
We are committed to supporting and promoting practical policy solutions that ensure patients with cancer have access to, and can afford, drugs vital to their treatment.
It's unacceptable that patients fall through the cracks of our health care system. Oncologists and patients need to sit at the table with policymakers to create real change.
Nominating Committee chair Dr. Lisa A. Carey encourages you to give a clear mandate to the Board by voting for your chosen leaders.
The most recent meeting of the AMA House of Delegates was a particularly important one for oncologists and cancer-related issues.
Dr. McAneny's broad expertise and insight on today’s challenging health care environment will greatly benefit the practice of medicine and our patients.
Preparing for the future starts with gaining clarity about the present state of oncology care. Our goal is for practices in all settings across the U.S. to provide feedback in the 2017 ASCO Practice Census.
If you say things of consequence, there may be consequences; but the alternative is to be inconsequential. Particularly in these tumultuous times for health care and research, we need to speak up!
Mr. Harvey D. Bichkoff offers a firsthand perspective of MACRA implementation at Marin Cancer Care, the private practice for which he serves as CEO.
We’re making progress in better understanding, and communicating, the many issues surrounding adverse events, although not as fast as we’d like. In the long run, our patients will benefit from all of these initiatives.
Sustaining this progress described in this report will be determined in large part by the level of federal investment in our nation's biomedical research enterprise.
ASCO soundly opposes President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health.
In the past 2 years, Bellevue Cancer Center's legal clinic saw more than 75 patients who were ineligible for lifesaving transplants or clinical trials due to their immigration status. Ms. Domna Antoniadis and Dr. Daniel Boxer outline the challenges faced by these patients.
Do you belong to your ASCO State/Regional Affiliate? If not, you should! Do you take advantage of all they have to offer? If not, you should! You, and more importantly your patients, will benefit enormously.
Policy issues fundamentally affect us, our practices, and most importantly, our patients. As I hope you are aware, ASCO has our backs.  Indeed, understanding and making meaningful changes to health policy has become a major focus of ASCO.  
We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid policies being adopted by many states. Many of the state legislations include language restricting...

Pages


Advertisement